A Clinical Trial of TQH3906 Capsules in Healthy Volunteers
Conditions: Psoriasis Interventions: Drug: TQH3906 capsule; Drug: TQH3906 placebo Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
Conditions: Plaque Psoriasis Interventions: Drug: JNJ-77242113; Drug: JNJ-77242113 Matching Placebo; Drug: Deucravacitinib; Drug: Deucravacitinib Matching Placebo Sponsors: Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms
Conditions: Psoriasis; Depressive Symptoms Interventions: Other: Coach-guided smartphone delivered CBT program. Sponsors: Brigham and Women ' s Hospital; National Psoriasis Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
Involvement of Pollutants in Atopic Dermatitis and Psoriasis
Conditions: Psoriasis; Atopic Dermatitis Interventions: Other: blood sampling; Other: urine sampling Sponsors: Assistance Publique Hopitaux De Marseille; ALPHENYX; Aix Marseille Universit é Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Botox Versus Calcipotriol in Psoriasis Vulgaris
Conditions: Psoriasis Vulgaris Interventions: Drug: Botulinum Toxin-A; Drug: calcipotriol Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
Conditions: Psoriasis Vulgaris; Psoriatic Arthritis Interventions: Drug: si-544; Drug: Placebo Sponsors: selectION Therapeutics GmbH; FGK Clinical Research GmbH Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices
Conditions: Moderate-to-Severe Plaque Psoriasis Interventions: Drug: SHR-1314; Drug: SHR-1314 Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Evaluation of Tolerability, Efficacy and Adherence to Treatment With Wynzora Cream
Conditions: Psoriasis Interventions: Other: questionnaire Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Conditions: Plaque Psoriasis Interventions: Drug: LY3972406; Drug: Placebo Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry
Conditions: Psoriatic Arthritis; Psoriasis Sponsors: Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY101 Ointment in Patients With Plaque Psoriasis
Conditions: Psoriasis, PDE-4 Inhibitors, Ointment Interventions: Drug: QY101/Placebo ointment Sponsors: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
A Study of QY101 Ointment in Subjects With Plaque Psoriasis
Conditions: Psoriasis Interventions: Drug: QY101Placebo/QY101 ointment Sponsors: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
The Relationship Between Moderate-to-severe Psoriasis and Sleep Disturbance
Conditions: Moderate-to-severe Psoriasis Interventions: Other: No intervention; Other: No intervention Sponsors: Shanghai Yueyang Integrated Medicine Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
The Effect of Ketogenic Diet Versus Mediterranean Diet in Patients With Obesity and Psoriatic Arthritis
Conditions: Obesity and Psoriasis Interventions: Other: Meditteranean Diet; Other: Ketogenic Diet Sponsors: Attikon Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
A Clinical Study of TQH2929 in Healthy Adult Subjects
Conditions: Psoriasis Interventions: Drug: TQH2929 injection; Drug: Placebo injection Sponsors: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
